Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
Bausch Health (NYSE:BHC) and its dentistry business OraPharma have launched OraTalks, a new podcast series focused on modern dentistry challenges. The inaugural nine-episode season, hosted by industry expert Melissa K. Turner, will explore critical topics including sleep disorders, women's health, and social determinants in oral healthcare.
The podcast aims to address significant oral health challenges, considering that nearly 65 million Americans are affected by gum disease. OraTalks will be available on major platforms like Apple Podcasts and Spotify starting September 29, 2025, with registration available at oratalks.com for exclusive updates.
Bausch Health (NYSE:BHC) e la sua divisione odontoiatrica OraPharma hanno lanciato OraTalks, una nuova serie podcast dedicata alle sfide dell'odontoiatria moderna. La prima stagione di nove episodi, condotta dall'esperta di settore Melissa K. Turner, esplorerà temi cruciali come i disturbi del sonno, la salute femminile e i determinanti sociali nelle cure orali.
Il podcast mira ad affrontare importanti sfide di salute orale, considerando che quasi 65 milioni di americani sono colpiti dalla malattia gengivale. OraTalks sarà disponibile sulle principali piattaforme come Apple Podcasts e Spotify a partire dal 29 settembre 2025, con la registrazione disponibile su oratalks.com per aggiornamenti esclusivi.
Bausch Health (NYSE:BHC) y su negocio de odontología OraPharma han lanzado OraTalks, una nueva serie de podcasts centrada en los retos de la odontología moderna. La primera temporada de nueve episodios, conducida por la experta del sector Melissa K. Turner, abordará temas críticos como los trastornos del sueño, la salud de la mujer y los determinantes sociales en la atención bucal.
El podcast busca abordar importantes desafíos de la salud bucal, considerando que casi 65 millones de estadounidenses padecen enfermedad de las encías. OraTalks estará disponible en plataformas principales como Apple Podcasts y Spotify a partir del 29 de septiembre de 2025, con registro disponible en oratalks.com para actualizaciones exclusivas.
Bausch Health (NYSE:BHC)와 구강의학 사업 OraPharma가 OraTalks를 출시했습니다. 현대 치의학의 도전과제를 다루는 새 팟캐스트 시리즈입니다. 초대된 9부작 시즌은 업계 전문가 Melissa K. Turner가 진행하며 수면 장애, 여성 건강, 구강 관리의 사회적 결정요인 등 중요한 주제를 탐구합니다.
이 팟캐스트는 잇몸 질환으로 고통받는 미국인 약 6500만 명이라는 사실을 감안해 주요 도전에 대응하는 것을 목표로 합니다. OraTalks는 Apple Podcasts 및 Spotify와 같은 주요 플랫폼에서 2025년 9월 29일에 시작되며, 독점 업데이트를 위한 등록은 oratalks.com에서 가능합니다.
Bausch Health (NYSE:BHC) et son activité dentaire OraPharma ont lancé OraTalks, une nouvelle série de podcasts axée sur les défis de l’odontologie moderne. La première saison de neuf épisodes, présentée par l’experte du secteur Melissa K. Turner, abordera des sujets cruciaux tels que les troubles du sommeil, la santé des femmes et les déterminants sociaux des soins bucco-dentaires.
Le podcast vise à relever d’importants défis en matière de santé bucco-dentaire, sachant que près de 65 millions d’Américains souffrent de maladie des gencives. OraTalks sera disponible sur les principales plateformes comme Apple Podcasts et Spotify à partir du 29 septembre 2025, avec une inscription possible sur oratalks.com pour des mises à jour exclusives.
Bausch Health (NYSE:BHC) und sein Zahnmedizin-Geschäft OraPharma haben OraTalks gestartet, eine neue Podcast-Reihe, die sich mit den Herausforderungen der modernen Zahnmedizin befasst. Die erste neunstufige Staffel wird von der Branchenexpertin Melissa K. Turner moderiert und behandelt zentrale Themen wie Schlafstörungen, Frauengesundheit und soziale Determinanten in der oralen Gesundheitsversorgung.
Der Podcast soll bedeutende Herausforderungen der Mundgesundheit ansprechen, zumal fast 65 Millionen Amerikaner von Zahnfleischerkrankungen betroffen sind. OraTalks wird ab dem 29. September 2025 auf großen Plattformen wie Apple Podcasts und Spotify verfügbar sein, eine Registrierung ist unter oratalks.com für exklusive Updates möglich.
بورش هيلث (NYSE:BHC) وشركتها في مجال طب الأسنان OraPharma أطلقا OraTalks، سلسلة بودكاست جديدة تركز على تحديات طب الأسنان الحديث. تتألف الموسم الأول من تسعة حلقات، مقدمة من خبيرة الصناعة Melissa K. Turner، و ستتناول مواضيع حاسمة مثل اضطرابات النوم، صحة المرأة، والعوامل الاجتماعية المؤثرة في رعاية الفم والأسنان.
يهدف البودكاست إلى معالجة تحديات صحة الفم الكبرى، مع مراعاة أن قرابة 65 مليون أمريكي يتأثرون بأمراض اللثة. سيكون OraTalks متاحاً على المنصات الرئيسية مثل Apple Podcasts وSpotify ابتداءً من 29 سبتمبر 2025، مع إمكانية التسجيل على oratalks.com للحصول على تحديثات حصرية.
Bausch Health (NYSE:BHC)及其牙科业务 OraPharma 已推出 OraTalks，一档专注于现代牙科挑战的新播客系列。首个九集季由行业专家 Melissa K. Turner主持，议题包括睡眠障碍、女性健康，以及口腔护理中的社会决定因素等关键话题。
该播客旨在应对重要的口腔健康挑战，考虑到 约有6500万美国人受牙龈疾病影响。OraTalks 将于 2025年9月29日 开始在 Apple Podcasts、Spotify 等主流平台上线，欢迎在 oratalks.com 注册以获取独家更新。
- None.
- None.
Designed for dental professionals, OraTalks connects leading voices with insights to spark meaningful dialogue.
Nine-episode inaugural season hosted by industry thought leader Melissa K. Turner, BASDH, RDHEP, EFDA, CHO.
Candid conversations with leading clinicians on the trends shaping today's dental landscape.
Episodes launch on September 29 on major podcast platforms; register now at oratalks.com for episode alerts and exclusive updates.
LAVAL, QC / ACCESS Newswire / September 29, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and its dentistry business, OraPharma, today announced the launch of OraTalks, a new podcast created to ignite meaningful dialogue and explore the challenges shaping modern dentistry.
Season One of OraTalks features nine episodes covering timely topics in oral health and patient care, such as sleep disorders, women's health, social determinants, and patient education. Hosted by Melissa K. Turner, BASDH, RDHEP, EFDA, CHO - a nationally recognized industry thought leader - the series combines her expertise with candid conversations from leading clinicians, researchers, and influencers. Listeners will also gain exclusive insights into emerging strategies shaping the future of dentistry.
"The goal of OraTalks is clear: to spark the conversations that truly matter in dentistry-conversations that are bold and timely," said Melissa K. Turner, BASDH, RDHEP, EFDA, CHO, Host, OraTalks Podcast. "OraTalks allows us to amplify these ideas and bring them directly to the clinicians, leaders, and visionaries shaping our industry. In today's rapidly evolving landscape, it's not enough to keep pace-we have to set the pace. OraTalks exists to challenge assumptions, spotlight innovation, and ensure we remain relevant to the needs of the dental community."
According to the American Dental Association, gum disease affects nearly 65 million Americans nationwide.1 This means millions of Americans may unknowingly have gum disease, underscoring the critical role dental professionals play in highlighting this serious condition.
"We're excited to introduce OraTalks as a new way to support dental professionals as they prioritize periodontal disease," said Tom Stern, General Manager and Vice President, Bausch Health. "This podcast reflects our commitment to listening, learning, and sharing insights that matter. We hope that by creating a space for meaningful conversations, we can help clinicians navigate the challenges of modern dentistry and continue delivering the best possible care for their patients."
OraTalks debuts on September 29, 2025, and is available on major platforms, including Apple Podcasts and Spotify. Upcoming episodes are listed on oratalks.com, where dental professionals can register to receive alerts and exclusive updates.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. OraPharma is a specialty pharmaceutical company committed to partnering with dental professionals to improve oral health. More information can be found at www.orapharma.com. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
ORAPHARMA is a trademark Bausch Health Companies Inc. or its affiliates.
© 2025 Bausch Health Companies Inc. or its affiliates.
1https://www.ada.org/resources/ada-library/oral-health-topics/periodontitis
Investor Contact:
Garen Sarafian
ir@bauschhealth.com
(877) 281-6642 (toll free)
Media Contact:
Katie Savastano
corporate.communications@bauschhealth.com
(908) 569-3692
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
FAQ
When and where can I listen to Bausch Health's OraTalks podcast?
Who is hosting the BHC OraTalks podcast and what topics will it cover?
How many episodes will be in the first season of OraTalks?
What is the purpose of Bausch Health's OraTalks podcast?
